tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
172 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $200.09M as of Dec 27, 2025. Its market cap has increase by 638.56% in one year.
Market Cap
$200.09M
Enterprise Value
$87.89M
1-Year Change
638.56%
Category
Micro (Under 300M)
Stock Price
$1.65

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Dec 26, 2025
142.01M+21.21%
Dec 24, 2025
117.15M+3.77%
Dec 23, 2025
112.89M-4.22%
Dec 22, 2025
117.86M-3.49%
Dec 19, 2025
122.13M+2.99%
Dec 18, 2025
118.57M+5.03%
Dec 17, 2025
112.89M-0.63%
Dec 16, 2025
113.60M-0.93%
Dec 15, 2025
114.67M+4.19%
Dec 12, 2025
110.05M+1.43%